Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.
Stay in the know with WPRI 12 News. Local news, weather, sports, and award winning investigative journalism coverage you can count on on this YouTube channel, TV, mobile app, our social channels and WPRI.com.
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
[ Ссылка ]
